Company Overview
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform designed specifically for seniors across the United States, delivering customized healthcare experiences through its Medicare Advantage plans to meet the evolving needs of the elderly population. The company functions within the broader healthcare sector and specifically the healthcare plans industry, positioning it as a key provider of managed care services and insurance solutions for the aging demographic. In terms of scale, the company holds a market capitalization of $3.71B and generates annual revenue of $3.95B, supporting an operational workforce of 1849 employees. These valuation and revenue figures indicate that Alignment Healthcare, Inc. has established a significant presence in the Medicare Advantage market, suggesting a substantial asset base and a capacity to manage large-scale healthcare delivery networks that distinguish it from smaller regional providers.
Financial Health
Alignment Healthcare, Inc. reported revenue of $3.95B for the trailing twelve months, yet recorded a net income of -$724,000 and an EBITDA of $46.11M, revealing a cost structure where operational expenses and interest obligations are high enough to erase net profitability despite generating substantial cash from operations. The company maintains robust financial flexibility with free cash flow of $124.50M, which provides the liquidity necessary to fund growth initiatives, repay debt, or invest in technology without relying solely on external capital markets. Margin analysis shows a gross margin of 12.4%, an operating margin of -1.1%, and a profit margin of -0.0%, indicating that while the company successfully generates revenue from its core services, its operating costs currently exceed its gross profit, resulting in a break-even or slight loss at the bottom line. On the balance sheet, the company holds $604.23M in cash against $331.60M in debt, with a debt-to-equity ratio of 184.97%, which suggests a leveraged capital structure where equity capital is lower relative to the debt load. Despite the leverage, the current ratio of 1.71 indicates a healthy short-term liquidity position, as the company holds sufficient current assets to cover its current liabilities with more than double the required coverage. Return on equity stands at -0.7% while return on assets is 1.1%, revealing that management is currently generating positive returns on the asset base but failing to generate sufficient returns on the shareholders' equity due to the net loss impacting the equity denominator.
Valuation Assessment
The valuation metrics present a mix of traditional and alternative measures, with a trailing P/E ratio of N/A and a forward P/E of 25.76, implying that the market expects earnings to turn positive or grow significantly to justify the current price multiple in the coming year. The price-to-book ratio is 20.68, indicating a substantial market premium over the company's book value, which often reflects investor expectations for future growth or the intangible value of the healthcare platform that is not captured on the balance sheet. Alternative valuation metrics such as the price-to-sales ratio of 0.94 and an EV/EBITDA of 74.54 suggest that the company is valued relative to its sales efficiency and earnings power before interest, taxes, depreciation, and amortization, though the high EV/EBITDA points to a premium valuation relative to its current EBITDA generation. The stock has traded between a 52-week high of $23.87 and a 52-week low of $11.62, and without a specific current share price provided in the facts, the relative positioning to this range remains undefined by the available data points. The beta of 1.19 indicates that the stock price is more volatile than the broader market, meaning it is expected to move approximately 19% more than the market in either direction during periods of fluctuation.
Growth & Income
Alignment Healthcare, Inc. demonstrated aggressive expansion with revenue growth of 44.4% year-over-year, while earnings growth is N/A due to the current net loss, implying that top-line expansion is currently outpacing profitability as the company scales its operations. As a non-dividend payer, the company does not distribute a dividend yield or maintain a payout ratio, indicating that management chooses to reinvest earnings and retained cash flows directly into business growth rather than returning capital to shareholders. This reinvestment strategy is consistent with the company's current financial health, where free cash flow of $124.50M allows for internal funding of strategic initiatives without the need for external equity dilution. The overall growth and income profile is characterized by rapid revenue expansion and a focus on capital allocation for future profitability rather than current income generation through dividends.